AFT Pharmaceuticals

Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products direct to pharmacies. AFT Pharmaceuticals was formed with a big dream in mind. In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 109 countries. Plus our Orphan Drugs Foundation provides access to lower cost pharmaceuticals for people with rare diseases within South East Asia and the Pacific.

Related News

PAOG ANNOUNCES CEO INTERVIEW DISCUSSING CANNABIS INVESTIGATIONAL NEW DRUG APPLICATION PLANS WITH FDA

PAO Group, Inc | October 05, 2020

news image

PAO Group, Inc. today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG's latest moves to engage a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). MoneyTV is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their ...

Read More

BUSINESS INSIGHTS

FSD PHARMA ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE

FSD Pharma Inc. | January 24, 2022

news image

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. “We have strategically assembled a team of scient...

Read More

ALTO, A PHARMACY START-UP, JUST RAISED $250 MILLION FROM SOFTBANK’S VISION FUND 2 AND OTHERS

CNBC: | January 30, 2020

news image

Alto Pharmacy has raised $250 million from investors including SoftBank’s second Vision Fund, three people familiar with the matter told CNBC. The investment has already been approved by the Vision Fund’s investment committee, meaning it’s a done deal, the sources said. It also marks one of the first handful of known bets from the SoftBank’s new fund. The deal values the company at more than $700 million, according to one of the people. SoftBank’s Vision Fund has al...

Read More

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

InvestorPlace | July 15, 2020

news image

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More
news image

PAOG ANNOUNCES CEO INTERVIEW DISCUSSING CANNABIS INVESTIGATIONAL NEW DRUG APPLICATION PLANS WITH FDA

PAO Group, Inc | October 05, 2020

PAO Group, Inc. today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG's latest moves to engage a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). MoneyTV is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their ...

Read More
news image

BUSINESS INSIGHTS

FSD PHARMA ANNOUNCES LAUNCH OF NEW CORPORATE WEBSITE

FSD Pharma Inc. | January 24, 2022

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website. The new site conveys the Company’s emerging position within the biopharmaceutical industry and its ongoing commitment to bring novel treatment solutions for brain and inflammatory disorders to millions of patients in need. “We have strategically assembled a team of scient...

Read More
news image

ALTO, A PHARMACY START-UP, JUST RAISED $250 MILLION FROM SOFTBANK’S VISION FUND 2 AND OTHERS

CNBC: | January 30, 2020

Alto Pharmacy has raised $250 million from investors including SoftBank’s second Vision Fund, three people familiar with the matter told CNBC. The investment has already been approved by the Vision Fund’s investment committee, meaning it’s a done deal, the sources said. It also marks one of the first handful of known bets from the SoftBank’s new fund. The deal values the company at more than $700 million, according to one of the people. SoftBank’s Vision Fund has al...

Read More
news image

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

InvestorPlace | July 15, 2020

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More